STYROFOAM(TM) SPF MX 2030 POLYOL 55gal

The Dow Chemical Company

Revision date : 2011-08-31

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

460-73-1

Name of the chemical

1,1,1,3,3-Pentafluoropropane

Concentration

N/A

EC/CAS

616-47-7

Name of the chemical

1-methylimidazole

Concentration

N/A

Listed in

EC/CAS

78-40-0

Name of the chemical

Phosphoric acid, triethyl ester, TEP

Concentration

N/A

Listed in

EC/CAS

102-71-6

Name of the chemical

triethanolamine

Concentration

N/A

EC/CAS

111-46-6

Name of the chemical

diethyleneglycol

Concentration

N/A

General Information

Revision date

2011-08-31

Product name

STYROFOAM(TM) SPF MX 2030 POLYOL 55gal

Icons in SDS

Company Information

company name

The Dow Chemical Company

GHS Information

Signal word

WARNING!

Section 2

SECTION 2: Hazards identification

OSHA Hazards Emergency Overview Color: Natural Physical State: Liquid. Odor: Amine. Hazards of product: WARNING! Causes eye irritation. May cause skin irritation. May be harmful if inhaled. Harmful if swallowed. Vapor reduces oxygen available for breathing. May cause anesthetic effects. May cause central nervous system effects; may cause respiratory tract irritation. Isolate area. Keep upwind of spill. OSHA Hazard Communication Standard This product is a "Hazardous Chemical" as defined by the OSHA Hazard Communication Standard, 29 CFR 1910.1200.

Potential health effects

Eye Contact: May cause severe eye irritation. May cause severe corneal injury. Vapor of amines may cause swelling of the cornea resulting in visual disturbances such as blurred or hazy vision. ®(TM)*Trademark Bright lights may appear to be surrounded by halos. Effects may be delayed and typically disappear spontaneously. Skin Contact: Prolonged contact may cause skin irritation with local redness. Skin Absorption: Prolonged skin contact is unlikely to result in absorption of harmful amounts. Massive contact with damaged skin or of material sufficiently hot to burn skin may result in absorption of potentially lethal amounts. Skin Sensitization For the minor component(s) Skin contact may cause an allergic skin reaction in a small proportion of individuals. Inhalation: Prolonged excessive exposure may cause adverse effects. In confined or poorly ventilated areas, vapor can easily accumulate and can cause unconsciousness and death due to displacement of oxygen. May cause respiratory irritation and central nervous system depression. Excessive exposure may increase sensitivity to epinephrine and increase myocardial irritability (irregular heartbeats). Symptoms of excessive exposure may be anesthetic or narcotic effects; dizziness and drowsiness may be observed. Ingestion: Ingestion of quantities (approximately 65 mL (2 oz.) for diethylene glycol or 100 mL (3 oz.) for ethylene glycol) has caused death in humans. Small amounts swallowed incidentally as a result of normal handling operations are not likely to cause injury; however, swallowing larger amounts may cause injury. The data presented are for the following material: Diethylene glycol. May cause nausea and vomiting. May cause abdominal discomfort or diarrhea. Excessive exposure may cause central nervous system effects, cardiopulmonary effects (metabolic acidosis), and kidney failure.

Aspiration hazard

Based on physical properties, not likely to be an aspiration hazard Effects of Repeated Exposure: Contains a component which is reported to be a weak organophosphate-type cholinesterase inhibitor. Excessive exposure may produce organophosphate type cholinesterase inhibition. Signs and symptoms of excessive exposure may be headache, dizziness, incoordination, muscle twitching, tremors, nausea, abdominal cramps, diarrhea, sweating, pinpoint pupils, blurred vision, salivation, tearing, tightness in chest, excessive urination, convulsions. Contains component(s) which have been reported to cause effects on the following organs in humans: Kidney. Contains component(s) which have been reported to cause effects on the following organs in animals: Liver. Respiratory tract. Heart.

Cancer information

For the minor component(s) Findings from a chronic skin painting study by NTP include liver tumors in mice. Mechanistic studies indicate that tumor formation is of questionable relevance to humans. Birth Defects/Developmental Effects: Diethylene glycol has caused toxicity to the fetus and some birth defects at maternally toxic, high doses in animals. Other animal studies have not reproduced birth defects even at much higher doses that caused severe maternal toxicity. Contains component(s) which did not cause birth defects in animals; other fetal effects occurred only at doses toxic to the mother. Reproductive Effects: Diethylene glycol did not interfere with reproduction in animal studies except at very high doses.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.